Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
Objective. To investigate the clinical value of lentinan combined with (125)I brachytherapy in the treatment of recurrent ovarian cancer. Methods. A total of 160 patients with recurrent ovarian cancer admitted at Jiaozhou Central Hospital from June 2009 to October 2015 were enrolled in this study an...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3ec21415ad0f426cafe3ae2c482a54b5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|